News blog


  • BY: Andrew Hore |
  • POSTED: 22/01/2018 |

Neuroscience-focused digital data analysis technology developer IXICO is increasing its revenues and this is cutting the reported loss.

Four contracts worth a total of £3m have been won in recent months. These contracts cover wearable biosensor and Huntingdon’s disease.

In the year to September 2017, revenues were one-quarter higher at £4.1m and the loss fell from £2.9m to £1.9m. There was £2.4m in the bank at the end of the period. Research and development tax credits reduced the cash outflow but it was still £693,000 over the 12 months.

IXICO founder Derek Hill has left the board.

At 35.1p, the share price is near to a 12 month high. 

© 2018 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds